Nicht lieferbar
Andere Kunden interessierten sich auch für
![Morphological and molecular diversity in cowpea]( "Morphological and molecular diversity in cowpea")
Morphological and molecular diversity in cowpea39,99 €![MOLECULAR PERSPECTIVES OF INSECTICIDE RESISTANCE IN INSECTS]( "MOLECULAR PERSPECTIVES OF INSECTICIDE RESISTANCE IN INSECTS")
MOLECULAR PERSPECTIVES OF INSECTICIDE RESISTANCE IN INSECTS26,99 €![Molecular characterization and Phylogenetic Studies of Tasar silkworm]( "Molecular characterization and Phylogenetic Studies of Tasar silkworm")
Molecular characterization and Phylogenetic Studies of Tasar silkworm40,99 €![MRI-Guided Prostate Motion Tracking]( "MRI-Guided Prostate Motion Tracking")
MRI-Guided Prostate Motion Tracking30,99 €![Vibrational excitation of molecules in the gas phase or embedded in matrices by ab initio molecular dynamics]( "Vibrational excitation of molecules in the gas phase or embedded in matrices by ab initio molecular dynamics")
Vibrational excitation of molecules in the gas phase or embedded in matrices by ab initio molecular dynamics36,99 €![Molecular Dynamics of Kapitza Resistance at the Solid-Liquid Interface]( "Molecular Dynamics of Kapitza Resistance at the Solid-Liquid Interface")
Molecular Dynamics of Kapitza Resistance at the Solid-Liquid Interface27,99 €![A Study on Molecular Aspects and Biomarkers]( "A Study on Molecular Aspects and Biomarkers")
A Study on Molecular Aspects and Biomarkers40,99 €
MEK inhibition alone was less effective in inducing cytotoxicity than taxanes indicating that a down-regulation of activated ERK1/2 may be necessary but is not sufficient for taxane-induced antitumoral effects. In line with this notion, we show in a xenograft mouse model that prostate cancer cells that are resistant to docetaxel overexpress activated ERK1/2. Taken together, our findings underscore that the modulation of ERK1/2 activation, in concert with other mechanisms, plays an important role in taxane-induced antineoplastic effects on prostate cancer cells.These results suggest at least partially nonoverlapping effects of docetaxel and androgen deprivation therapy and hence help to understand recent clinical findings. A further elucidation of the mode of action of docetaxel would have important implications to optimize current treatment strategies and biomarker development for men with metastatic prostate cancer.